{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:48:28Z","timestamp":1785757708811,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16251-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:45:43Z","timestamp":1780026343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Staining pattern and clinicopathological features of Epstein-Barr virus, Latent Membrane protein 1 expression in patients with gastric carcinoma in Lake zone, Tanzania"],"prefix":"10.1186","volume":"26","author":[{"given":"Athuman","family":"Chalamila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edrick","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Ottoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subira","family":"Matiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmas","family":"Mbulwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Kahima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idd","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroan","family":"Orgenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Mremi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"3","key":"16251_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin Am Cancer Soc. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin Am Cancer Soc"},{"key":"16251_CR2","doi-asserted-by":"crossref","unstructured":"Mabula JB, Mchembe MD, Koy M, Chalya PL, Massaga F, Rambau PF et al. Gastric cancer at a university teaching hospital in northwestern Tanzania: a retrospective review of 232 cases. World J Surg Oncol. 2012;10:257. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3527214\/.\u00a0Cited 4 Apr 2026.","DOI":"10.1186\/1477-7819-10-257"},{"key":"16251_CR3","doi-asserted-by":"publisher","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138. Available from: https:\/\/doi.org\/10.1111\/his.13975.\u00a0Cited 16 Dec 2025.","DOI":"10.1111\/his.13975"},{"key":"#cr-split#-16251_CR4.1","unstructured":"Jim\u00e9nez Fonseca P, Carmona-Bayonas A, Hern\u00e1ndez R, Custodio A, Cano JM, Lacalle A et al. Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry. Br J Cancer 2017 1176. Nature Publishing Group"},{"key":"#cr-split#-16251_CR4.2","unstructured":"2017;117(6):775-82. Available from: https:\/\/www.nature.com\/articles\/bjc2017245. Cited 16 Dec 2025."},{"key":"16251_CR5","doi-asserted-by":"crossref","unstructured":"Shechter O, Sausen DG, Gallo ES, Dahari H, Borenstein R. Epstein\u2013Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments. Int J Mol Sci. MDPI; 2022;23(22):14389. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9699474\/. Cited 16 Dec 2025.","DOI":"10.3390\/ijms232214389"},{"key":"16251_CR6","doi-asserted-by":"crossref","unstructured":"Nishikawa J, Yoshiyama H, Iizasa H, Kanehiro Y, Nakamura M, Nishimura J et al. Epstein-Barr Virus in Gastric Carcinoma. Cancers (Basel). 2014;6:2259\u201374. Available from: https:\/\/www.mdpi.com\/journal\/cancers. Cited 16 Dec 2025.","DOI":"10.3390\/cancers6042259"},{"issue":"17","key":"16251_CR7","first-page":"169","volume":"8","author":"M Aslane","year":"2016","unstructured":"Aslane M, Al Haj A, Henneb A, Khenchouche A, Houali K. Characteristics of gastric carcinoma associated with epstein barr virus in Algeria. Der Pharm Lett. 2016;8(17):169\u201378.","journal-title":"Der Pharm Lett"},{"key":"16251_CR8","doi-asserted-by":"crossref","unstructured":"Benayed-Guerfali D, Ayadi W, Miladi-Abdennadher I, Khabir A, Sellami-Boudawara T, Gargouri A et al. Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia. 2011; Available from: http:\/\/www.virologyj.com\/content\/8\/1\/500. Cited 16 Dec 2025.","DOI":"10.1186\/1743-422X-8-500"},{"key":"16251_CR9","doi-asserted-by":"crossref","unstructured":"Samir S, Ahmed HO, Diab TM, Mostafa A, Elmeligy HA, Kamel A et al. Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity. Open Access Maced J Med Sci. Scientific Foundation SPIROSKI; 2022;10(A):1218\u201325. Available from: https:\/\/oamjms.eu\/index.php\/mjms\/article\/view\/9700\/7812. Cited 16 Dec 2025.","DOI":"10.3889\/oamjms.2022.9700"},{"key":"16251_CR10","unstructured":"Yanagi A, Nishikawa J, Shimokuri K, Shuto T, Takagi T, Takagi F et al. microorganisms Clinicopathologic Characteristics of Epstein-Barr Virus-Associated Gastric Cancer Over the Past Decade in Japan. [cited 2025 Dec 16]; Available from: www.mdpi.com\/journal\/microorganisms"},{"key":"16251_CR11","doi-asserted-by":"crossref","unstructured":"Benakli Y, Khenchouche A, Rabea S, Mansour AA, Salem-Bekhit MM, Taha EI et al. Characterizing EBV-associated Gastric Carcinoma (EBVaGC): A deep dive into LMP1 expression patterns. Cell Mol Biol (Noisy-le-grand). Cell Mol Biol (Noisy-le-grand); 2023;69(13):217\u201324. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38158662\/. Cited 16 Dec 2025.","DOI":"10.14715\/cmb\/2023.69.13.33"},{"key":"16251_CR12","doi-asserted-by":"crossref","unstructured":"Nursal AF, Nursal AF. Epstein-Barr Virus and DNA Methylation in Gastric Cancer. Istanbul Med J. 2016;17(1):1\u20134. Available from: https:\/\/www.istanbulmedicaljournal.org. Cited 16 Dec 2025.","DOI":"10.5152\/imj.2016.28482"},{"key":"16251_CR13","doi-asserted-by":"crossref","unstructured":"Fukayama M, Ushiku T. Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. Pathol Res Pract; 2011;207(9). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21944426\/. Cited 16 Dec 2025.","DOI":"10.1016\/j.prp.2011.07.004"},{"key":"16251_CR14","doi-asserted-by":"crossref","unstructured":"Akiba S, Koriyama C, Herrera-Goepfert R, Eizuru Y. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci. Cancer Sci; 2008;99(2):195\u2013201. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18271915\/. Cited 16 Dec 2025.","DOI":"10.1111\/j.1349-7006.2007.00674.x"},{"key":"16251_CR15","doi-asserted-by":"crossref","unstructured":"Gharibzadeh M, Jalilian S, Makvandi M, Seyedian SS, Azaran A. Molecular detection of Epstein-Barr virus in paraffin-embedded tissue samples of patients suffering gastric cancer in Ahvaz, Iran: a case-control study. Iran J Microbiol. Tehran University of Medical Sciences; 2024;16(5):689. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11551666\/. Cited 4 Apr 2025.","DOI":"10.18502\/ijm.v16i5.16805"},{"key":"16251_CR16","doi-asserted-by":"crossref","unstructured":"Ryan JL, Morgan DR, Dominguez RL, Thorne LB, Elmore SH, Mino-Kenudson M et al. High levels of Epstein\u2013Barr virus DNA in latently infected gastric adenocarcinoma. Lab Investig. Elsevier; 2009;89(1):80\u201390. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0023683722014933#bib34.\u00a0Cited 6 Apr 2026.","DOI":"10.1038\/labinvest.2008.103"},{"key":"16251_CR17","doi-asserted-by":"crossref","unstructured":"Srinivasan M, Sedmak D, Jewell S, American Society for Investigative Pathology Inc. Effect of Fixatives and Tissue Processing on the Content and Integrity of Nucleic Acids. Am J Pathol. 2002;161(6):1961. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC1850907\/.\u00a0Cited 6 Apr 2026.","DOI":"10.1016\/S0002-9440(10)64472-0"},{"issue":"December","key":"16251_CR18","first-page":"1","volume":"10","author":"K Sun","year":"2020","unstructured":"Sun K, Jia K, Lv H, Wang SQ, Wu Y, Lei H, et al. EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives. Front Oncol. 2020;10(December):1\u201311.","journal-title":"Front Oncol"},{"key":"16251_CR19","doi-asserted-by":"crossref","unstructured":"Lee MA, Hong YS, Kang JH, Lee KS, You JY, Lee KY et al. Detection of Epstein-Barr Virus by PCR and Expression of LMP1, p53, CD44 in Gastric Cancer. Korean J Intern Med. Korean Association of Internal Medicine; 2004;19(1):43. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4531546\/. Cited 6 Apr 2026.","DOI":"10.3904\/kjim.2004.19.1.43"},{"key":"16251_CR20","doi-asserted-by":"crossref","unstructured":"Rahman R, Poomsawat S, Juengsomjit R, Buajeeb W. Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma. BMC Oral Health. BMC Oral Health; 2019;19(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31291930\/. Cited 6 Apr 2026.","DOI":"10.1186\/s12903-019-0832-3"},{"key":"16251_CR21","doi-asserted-by":"crossref","unstructured":"Wang A, Zhang W, Jin M, Zhang J, Li S, Tong F et al. Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues. Mol Med Rep. Spandidos Publications; 2016;13(5):4151\u20138. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4838144\/.\u00a0Cited 16 Dec 2025.","DOI":"10.3892\/mmr.2016.5087"},{"issue":"4","key":"16251_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers10040086","volume":"10","author":"KHY Shair","year":"2018","unstructured":"Shair KHY, Reddy A, Cooper VS. New insights from elucidating the role of LMP1 in nasopharyngeal carcinoma. Cancers (Basel). 2018;10(4):1\u201322.","journal-title":"Cancers (Basel)"},{"key":"16251_CR23","doi-asserted-by":"crossref","unstructured":"He J, Tang F, Liu L, Chen L, Li J, Ou D et al. Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma. Oncotarget. Impact Journals LLC; 2016;8(32):52333. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5581032\/. Cited 16 Dec 2025.","DOI":"10.18632\/oncotarget.13775"},{"key":"16251_CR24","doi-asserted-by":"crossref","unstructured":"Aka P, Kawira E, Masalu N, Emmanuel B, Brubaker G, Magatti J et al. Incidence and Trends in Burkitt Lymphoma in Northern Tanzania from 2000 to 2009. Pediatr Blood Cancer. 2012;59(7):1234. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3427713\/. Cited 16 Dec 2025.","DOI":"10.1002\/pbc.24194"},{"issue":"October","key":"16251_CR25","first-page":"1","volume":"12","author":"X Cui","year":"2021","unstructured":"Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol. 2021;12(October):1\u201316.","journal-title":"Front Immunol"},{"key":"16251_CR26","doi-asserted-by":"crossref","unstructured":"Van Zyl DG, Mautner J, Delecluse HJ. Progress in EBV Vaccines. Front Oncol. Front Oncol; 2019;9(FEB). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30859093\/. Cited 16 Dec 2025.","DOI":"10.3389\/fonc.2019.00104"},{"key":"16251_CR27","doi-asserted-by":"crossref","unstructured":"Trimeche M, Ksi\u011da F, Ziadi S, Mestiri S, Hachana M, Gacem R, Ben et al. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Tunisia. Eur J Gastroenterol Hepatol. Eur J Gastroenterol Hepatol; 2009;21(9):1001\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19491698\/. Cited 16 Dec 2025.","DOI":"10.1097\/MEG.0b013e32831f1f53"},{"key":"16251_CR28","doi-asserted-by":"crossref","unstructured":"Kattoor J, Koriyama C, Akiba S, Itoh T, Ding S, Eizuru Y et al. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series. J Med Virol. J Med Virol; 2002;68(3):384\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12226826\/. Cited 16 Dec 2025.","DOI":"10.1002\/jmv.10215"},{"key":"16251_CR29","doi-asserted-by":"crossref","unstructured":"Lee HS, Chang MS, Yang HK, Lee BL, Kim WH. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma. Clin Cancer Res. Clin Cancer Res; 2004;10(5):1698\u2013705. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15014022\/. Cited 16 Dec 2025.","DOI":"10.1158\/1078-0432.CCR-1122-3"},{"issue":"6","key":"16251_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/(SICI)1097-0215(19971210)73:6<786::AID-IJC2>3.0.CO;2-Z","volume":"73","author":"SA Galetsky","year":"1997","unstructured":"Galetsky SA, Tsvetnov VV, Land CE, Afanasieva TA, Petrovichev NN, Gurtsevitch VE, et al. Epstein-Barr-Virus-associated gastric cancer in Russia. Int J Cancer. 1997;73(6):786\u20139.","journal-title":"Int J Cancer"},{"key":"16251_CR31","doi-asserted-by":"crossref","unstructured":"van Beek J, zur Hausen A, Kranenbarg EK, van de Velde CJH, Middeldorp JM, van den Brule AJC et al. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol. J Clin Oncol; 2004;22(4):664\u201370. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/14966089\/. Cited 16 Dec 2025.","DOI":"10.1200\/JCO.2004.08.061"},{"key":"16251_CR32","doi-asserted-by":"crossref","unstructured":"Constanza Camargo M, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. Gut; 2014;63(2):236\u201343. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23580779\/. Cited 16 Dec 2025.","DOI":"10.1136\/gutjnl-2013-304531"},{"key":"16251_CR33","doi-asserted-by":"crossref","unstructured":"Osumi H, Kawachi H, Murai K, Kusafuka K, Inoue S, Kitamura M et al. Risk stratification for lymph node metastasis using Epstein-Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study. Gastric Cancer. Gastric Cancer; 2019;22(6):1176\u201382. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31062195\/. Cited 16 Dec 2025.","DOI":"10.1007\/s10120-019-00963-7"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16251-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:24:20Z","timestamp":1785756260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16251-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16251"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16251-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8529407\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was given by the joint CUHAS\/BMC Research Ethics and Review Committee before the commencement of the study, with clearance certificate number CREC\/863\/2024.Informed consent was waived, as no contact was made with the participants and instead the secondary was used.The study adhered to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"927"}}